NTI164 in Autism Spectrum Disorder | MicrobiomeTrials← Back to trialsNCT07257939
NTI164 in Autism Spectrum Disorder
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-09-30Est. Completion: 2029-07-01
Enrollment target: 98 participants Locations- Monash Health, Clayton, Victoria, Australia
Other microbiome trials you might be interested in
Autism Spectrum Disorder
This is an 18 to 54 week study assessing the efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI16…
Clayton, AustraliaCompleted Mar 1, 2024
Autism Spectrum DisorderSibling Relations
The purpose of this study was to evaluate the effectiveness of a novel psychoeducational program for adult siblings of a…
Heraklion, GreeceCompleted Oct 30, 2024
Recruiting
AutismDepressedDepressed Mood
Autism spectrum disorder is characterized by differences in social communication/interaction and the presence of restric…
Stony Brook, United StatesEst. completion Sep 2027